CERTANIA Acquires Bioarray Genetic Diagnosis

July 9, 2025

CERTANIA, a Munich-based Testing, Inspection and Certification (TIC) group, has acquired Spanish genetic diagnostics lab Bioarray, which will join CERTANIA’s global network. Bioarray — headquartered in Elche (Alicante) — will continue to be led by cofounder Andrés Antón Salas and will leverage CERTANIA’s platform to expand its genomic diagnostics and research services internationally.

Targets
Bioarray Genetic Diagnosis (Bioarray S.L.)
Location
Alicante, Spain
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.